Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.
Alexandre SeprianoJosef S SmolenOliver M FitzGeraldMikkel ØstergaardJoanne HomikDésirée Mfm van der HeijdeOri ElkayamJ Carter ThroneMaggie J LarchéGianfranco FerraccioliMarina BackhausGerd-Rüdiger R BurmesterGilles BoireBernard CombeThierry SchaeverbekeAlain SarauxMaxime DougadosMaurizio RossiniMarcello GovoniLuigi SinigagliaAlain CantagrelCheryl C M BarnabeClifton O BinghamPaul P TakDirkjan van SchaardenburgHilde Berner HammerJoel PaschkeRana DadashovaEdna HutchingsRobert B M LandeweWalter P MaksymowychPublished in: The Journal of rheumatology (2019)
Lack of adherence to T2T in the RA BIODAM cohort was evident in a substantial proportion despite being a protocol requirement, and this could be predicted by clinical features. [Rheumatoid Arthritis (RA) BIODAM cohort; ClinicalTrials.gov: NCT01476956].